VGW.V - Valens GroWorks Corp.

TSXV - TSXV Delayed Price. Currency in CAD
3.1000
+0.0500 (+1.64%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close3.0500
Open3.0300
Bid3.0700 x N/A
Ask3.1000 x N/A
Day's Range2.9700 - 3.1000
52 Week Range2.6000 - 4.6900
Volume306,310
Avg. Volume388,278
Market Cap389.062M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateOct 14, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.45
  • The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'
    PR Newswire

    The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'

    Valens GroWorks Corp (TSXV: VLNS) (OTCQX: VLNCF) (the "Company", "Valens" or "The Valens Company") a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce a multi-year extraction and white label agreement with Emerald Health Therapeutics Inc. ("Emerald Heath"), a multi-year product supply agreement with Dynaleo Inc. ("Dynaleo"), and an update of its OTCQX stock ticker to VLNCF.

  • The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'
    CNW Group

    The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'

    Valens enters into multi-year distillate and SōRSE emulsion supply agreement with large-scale confectionary company, Dynaleo Inc. KELOWNA, B.C , Dec. 23, 2019 /CNW/ - Valens GroWorks Corp (VLNS.V) (OTCQX:VLNCF) (the "Company", "Valens" or "The Valens Company") a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce a multi-year extraction and white label agreement with Emerald Health Therapeutics Inc. (" Emerald Heath "), a multi-year product supply agreement with Dynaleo Inc. ("Dynaleo"), and an update of its OTCQX stock ticker to VLNCF.

  • The Valens Company Announces TSXV Approval of Normal Course Issuer Bid
    PR Newswire

    The Valens Company Announces TSXV Approval of Normal Course Issuer Bid

    Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company", "Valens" or "The Valens Company"), a vertically integrated provider of industry leading extraction products and services, including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, announced today that the TSX Venture Exchange (the "TSXV") has approved its notice of intention to make a normal course issuer bid for its common shares ("Shares") as appropriate opportunities arise from time to time. Valens' normal course issuer bid will be made in accordance with the policies of the TSXV. Valens may purchase its Shares during the period from December 19, 2019 to December 18, 2020.

  • Valens GroWorks Corp. rebrands to 'The Valens Company' demonstrating leadership in both extraction and commercializing innovative, cannabinoid-based products
    PR Newswire

    Valens GroWorks Corp. rebrands to 'The Valens Company' demonstrating leadership in both extraction and commercializing innovative, cannabinoid-based products

    Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" "Valens" or "The Valens Company"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, announced today that it is rebranding to 'The Valens Company,' and effective at market open on December 19, 2019, will trade on the TSXV under the ticker VLNS. The rebrand solidifies the Company's focus on the development and manufacturing of innovative cannabis products and marks its commitment to enter high-value international markets in 2020.

  • Valens GroWorks Corp. rebrands to 'The Valens Company' demonstrating leadership in both extraction and commercializing innovative, cannabinoid-based products
    CNW Group

    Valens GroWorks Corp. rebrands to 'The Valens Company' demonstrating leadership in both extraction and commercializing innovative, cannabinoid-based products

    KELOWNA , Dec. 17, 2019 /CNW/ - Valens GroWorks Corp. (VGW.V) (VGWCF) (the "Company" "Valens" or "The Valens Company"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, announced today that it is rebranding to 'The Valens Company,' and effective at market open on December 19, 2019 , will trade on the TSXV under the ticker VLNS. The rebrand solidifies the Company's focus on the development and manufacturing of innovative cannabis products and marks its commitment to enter high-value international markets in 2020.

  • Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid
    PR Newswire

    Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid

    Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a cannabinoid-based product company with industry leading extraction, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce revenue guidance for the recently completed fourth quarter 2019 in the range of $27 million to $30 million as well as its intention to commence a NCIB for the purchase and cancellation of up to 6,275,204 of its common shares (the "Shares") or 5% of the issued and outstanding Shares as calculated on a non-diluted basis. The NCIB will be funded with cash on hand and the Company's current positive cash flow from operations.

  • Benzinga

    Valens Expands Exclusive License Agreement With SōRSE Technology To Reach Global Markets

    Vertically-integrated cannabis company Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) said Wednesday it has signed an amended manufacturing and sales license agreement with SōRSE Technology Corporation. The expanded license agreement provides Valens with an exclusive license to utilize SōRSE emulsion technology for the production, packaging, sales, and distribution of cannabis-infused products in Europe, Mexico, and Australia, in addition to Canada. The SōRSE emulsion technology converts cannabis oil into water-soluble forms to be used in various final products, such as topicals, edibles, and beverages, enabling these products to keep its potency when frozen, chilled, or heated.

  • Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets
    CNW Group

    Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets

    KELOWNA, BC , Dec. 11, 2019 /CNW/ - Valens GroWorks Corp. (VGW.V) (VGWCF) (the "Company" or "Valens"), a cannabinoid-based product company with industry leading extraction, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce that it has entered an amended manufacturing and sales licence agreement with SōRSE Technology Corporation ("SōRSE") which grants Valens an exclusive licence for Canada , Europe , Australia and Mexico to use the proprietary SōRSE emulsion technology ("the Technology") to produce, market, package, sell and distribute cannabis-infused products (the "Agreement").

  • Valens establishes operations in The Greater Toronto Area with the acquisition of a leading beverage company
    CNW Group

    Valens establishes operations in The Greater Toronto Area with the acquisition of a leading beverage company

    Valens establishes operations in The Greater Toronto Area with the acquisition of a leading beverage company

  • Valens and BRNT Enter into Major White Label Deal with a Gross Revenue Potential to Valens of More Than $50 Million
    CNW Group

    Valens and BRNT Enter into Major White Label Deal with a Gross Revenue Potential to Valens of More Than $50 Million

    KELOWNA, BC , Oct. 30, 2019 /CNW/ - Valens GroWorks Corp. (TSXV:VGW) (VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to announce a multi-year white label agreement (the "Agreement") with BRNT Ltd ("BRNT"), a leading, premium, cannabis ancillary company to launch a line of unique cannabis vape pens in Canada . Under the terms of the Agreement, Valens will provide high-quality cannabis extracts, filling services and national distribution of a line of custom-formulated BRNT-branded vape pens. The initial term of the Agreement will be for two years, with two successive one year renewal options, and relates to the production and sale of a guaranteed minimum of 2.2 million BRNT-branded vape pens, with the gross revenue potential to Valens under the Agreement of over $50 million in the first two years, all subject to final acceptance from provincial distributors, including of the proposed price per unit.

  • Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
    CNW Group

    Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019

    Net income of $5.9 million (or $0.05 per share basic and diluted) in the third quarter, compared to a net loss of $10.5 million (or a loss of $0.10 per share basic and diluted) in the second quarter of 2019. "We are extremely pleased with the roll-out of our business plan and the continued scale up in the Company's extraction operations which have allowed us to continue our aggressive quarter over quarter growth in volumes, revenue, adjusted EBITDA and net income." said Tyler Robson , CEO of Valens. "The Company's performance in the third quarter clearly demonstrates our industry leading technical capabilities, the quality of our products and the earnings power of our platform.

  • Newsfile

    Benzinga Announces: Valens GroWorks Corp. Presenting at the Cannabis Capital Conference in Chicago

    Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound. For more information and/or to register for the conference please visit: ...

  • Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019
    CNW Group

    Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019

    Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019

  • Valens Announces Results of Annual General and Special Meeting of Shareholders
    CNW Group

    Valens Announces Results of Annual General and Special Meeting of Shareholders

    Valens Announces Results of Annual General and Special Meeting of Shareholders

  • Market Exclusive

    Cannabis Stock News Daily Roundup September 24

    Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) (Frankfurt: 0QV) has extended the expiry date of 27,235,027 share purchase warrants issued on October 1, 2018, for one year in conjunction with the company's non-brokered private placement of $25 million. Each warrant entitles the holder to purchase one subordinate voting share of Dixie at an exercise price of $1.32 per share. […]The post Cannabis Stock News Daily Roundup September 24 appeared first on Market Exclusive.

  • Market Exclusive

    Valens Gets Approval to Sell Cannabis Oil Directly to Distributors

    Valens GroWorks (TSXV: VGW) (OTCQX: VGWCF) announced that it has received an amended license from Health Canada related to the sale of its oil products as well as reported an update on the progress to build a white label manufacturing facility. New License a Significant Milestone The new license allows Valens to manufacture and supply oil […]The post Valens Gets Approval to Sell Cannabis Oil Directly to Distributors appeared first on Market Exclusive.

  • Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
    CNW Group

    Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update

    Under the new license, Valens is now authorized to manufacture and supply oil products directly to provincial distributors and other authorized Canadian retail supply channels. Valens will immediately start leveraging this amended license to expand services provided to its white label manufacturing partners, delivering retail ready products including tinctures and gel caps.  The Company plans to further expand its retail ready product offerings to include vaporizer cartridges, beverages, topicals and other desired products as permitted by Health Canada.

  • Market Exclusive

    Valens Picks Iconic Brewing to Sell Cannabis-Infused Beverages

    Valens GroWorks (TSXV: VGW) (OTCQX: VGWCF) has entered into a five-year, white-label cannabis-infused beverage contract with the cannabis division of Iconic Brewing. Under the white label agreement, Valens will provide high-quality extracts, formulation services, and SōRSE emulsion IP for its cannabis-infused beverages. Whereas, Iconic will brand and market the final product across Canada. Under the terms of the […]The post Valens Picks Iconic Brewing to Sell Cannabis-Infused Beverages appeared first on Market Exclusive.

  • Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products
    PR Newswire

    Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products

    KELOWNA, BC , Sept. 16, 2019 /PRNewswire/ -  Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF)  (the " Company " or " Valens "), a vertically integrated provider of industry leading extraction ...

  • Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company's Cannabis Division
    CNW Group

    Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company's Cannabis Division

    Valens is excited to announce a white label agreement with Iconic to provide high quality extracts, formulation services, and SōRSE™ emulsion IP for its cannabis infused beverages. Iconic will brand and market the final product across Canada . "We are thrilled to partner with Iconic Brewing, one of the fastest growing alcohol beverage companies in eastern Canada , to help create their new line of cannabis-infused beverages," said Tyler Robson , CEO of Valens.

  • Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
    CNW Group

    Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th

    The Company expects to report that it has extracted over 26,000 kilograms of cannabis and hemp biomass in the third quarter of 2019. This represents a significant ramp in extraction volumes compared with the 8,547 kilograms of dried cannabis and hemp biomass it processed in the second quarter of 2019, driven by the build out of the Company's ethanol extraction capabilities and increasing volumes from our new and existing customers.